Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer

The use of genomics to discover novel targets and biomarkers has placed the field of oncology at the forefront of precision medicine. First-generation epidermal growth factor receptor (EGFR) inhibitors have transformed the therapeutic landscape of EGFR mutant non-small-cell lung carcinoma through th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yap, Timothy A, Popat, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178554/
https://www.ncbi.nlm.nih.gov/pubmed/25278773
http://dx.doi.org/10.2147/PGPM.S55339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178554/
https://www.ncbi.nlm.nih.gov/pubmed/25278773
http://dx.doi.org/10.2147/PGPM.S55339

Ejemplares similares